Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for political professionals · Thursday, March 28, 2024 · 699,431,721 Articles · 3+ Million Readers

Veterinary Pharmaceutical Submissions in the EU (London, United Kingdom - May 22-23, 2019)

Dublin, May 20, 2019 (GLOBE NEWSWIRE) -- The "Veterinary Pharmaceutical Submissions in the EU" conference has been added to ResearchAndMarkets.com's offering.

Presentations will cover the regulatory framework, pharmaceutical, toxicological and pharmacological data, safety risk assessments, pre-clinical and clinical data, Detailed and Critical Summaries and regulatory submissions

Course Overview

This course will take participants through all of the constituent parts of the application for marketing authorisation for a veterinary medicinal product in the European Union, including the maximum residue limits dossier.

Presentations will cover the regulatory framework; pharmaceutical, toxicological and pharmacological data; safety risk assessments; pre-clinical and clinical data; detailed and critical summaries; and regulatory submissions. An important part of the programme will be devoted to working on case studies in the workshop sessions.

This practical two-day In-house course will take participants through all of the constituent parts of the application for marketing authorisation for a veterinary medicinal product for which a marketing authorisation is sought in the European Union, including the Maximum Residue Limits dossier. Presentations will cover the regulatory framework, pharmaceutical, toxicological and pharmacological data, safety risk assessments, pre-clinical and clinical data, Detailed and Critical Summaries and regulatory submissions. An important part of the course will be devoted to working on case studies in the workshop sessions. The course will provide a comprehensive introduction to the entire regulatory dossier for a veterinary medicinal product in the European Union.

BENEFITS OF ATTENDING

  • Understand the EU Regulatory Framework
  • Learn the Pharmaceutical Data Requirements
  • Know how to Comply with the Safety Requirements
  • Review the User Safety Risk Assessment
  • Consider the Environmental Risk Assessment
  • Receive Guidance on the Safety' Detailed and Critcal Summary
  • Consider the Pre-Clinical and Clinical Requirements
  • Take Away Regulatory Strategies and Procedures
  • Know How to Write the Regulatory Submission

Who Should Attend:

Personnel working in the following departments: Regulatory Affairs, Research and Development and Clinical Trials and Marketing. It will also be valuable to those seeking to review special problems encountered in the registrations of veterinary medicines. There will be ample opportunity for discussion during the proceedings.

Agenda:

Programme Day One

09.30 Introduction and Objectives of the course

09.45 EU Regulatory Framework

  • Understanding the regulatory objectives
  • EU legal framework
  • Legal base of regulatory procedures and dossier requirements

10.45 Refreshments

11.00 Part II: Pharmaceutical Data Requirements

  • Formulation and analytical data
  • Manufacturing process
  • Stability Studies

12.15 Discussion

12.30 Lunch

13.30 Workshop session
Planning a dossier to contain:

  • Pharmaceutical development studies
  • Toxicological, pharmacokinetic, metabolism and residue studies
  • Pre-clinical and clinical studies

14.45 Part IIIA: Consumer and Environmental Safety Data Requirements

  • The Toxicological Package
  • Maximum Residue Limits dossier: Safety File
  • Part IIIA of the Marketing Authorisation Application

15.15 User Safety Risk Assessment

  • Reviewing toxicology studies
  • Setting the scenario
  • Risk assessment and management

15.45 Refreshments

16.00 Pharmacokinetics and Bioequivalence

17.00 End of Day One

Programme Day Two

09.00 Environmental Risk Assessment

  • Phase I and II Assessments

09.30 Part IIIB Residues

  • Metabolism and residue studies
  • Maximum Residue Limits dossier: Residues File
  • Withdrawal period
  • Part IIIB of the Marketing Authorisation Application

10.15 Safety and Residues' Detailed and Critical Summaries

10.30 Refreshments

10.45 Part IV Pre-Clinical Data

  • Pharmacodynamics and pharmacokinetics
  • Target species tolerance
  • Resistance

11.15 Part IV Clinical Data and Clinical' Detailed and Critical Summary

  • Clinical trials
  • Clinical Detailed and Critical Summary

11.45 EU Regulatory Strategies and Procedures

  • Full and abbreviated applications
  • Generic applications
  • Centralised Procedure
  • Decentralised, MRP and National Procedures

12.30 Lunch

14.00 Workshop Session

15.00 Refreshments

15.15 Workshop Presentations

  • Presentation by each team
  • Review and discussion

15.45 Writing the Regulatory Submission

  • Writing the dossier
  • Summary of Product Characteristics and labelling
  • Working with writers of Detailed and Critical Summaries

16.45 Discussion

17.00 End of Course

For more information about this conference visit https://www.researchandmarkets.com/r/v4q2ch

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Animal Healthcare/Veterinary
                    

22157.jpg

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release